In vivo cerebrovascular actions of amyloid β-peptides and the protective effect of conjugated estrogens

Journal of Alzheimer's Disease

Volumn 5, Issue 4, 2003, Pages 275-286

  Rhodin, Johannes A ^a   Thomas, Tom N ^a,b   Clark, Linda ^a   Garces, Amanda ^a   Bryant, Margaret ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Woodlands Med and Research Center   (United States)

Author keywords

Alzheimer's disease; Amyloid proteins; Conjugated estrogens; Cranial window technique; Inflammation; Leukocyte platelet endothelial interaction; Thrombosis

Indexed keywords

AMYLOID BETA PROTEIN; CONJUGATED ESTROGEN; RHODAMINE 6G;

ALZHEIMER DISEASE; ARTICLE; BLOOD VESSEL INJURY; CELL DAMAGE; CELL PROTECTION; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR DISEASE;

EID: 0242636129     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2003-5403     Document Type: Article

References (55)

1. H. Baatz, M. Steinbauer, A.G. Harris and F. Krombach, Kinetics of white blood cell staining by intravascular administration of rhodamine 6G, Int J Microcirc Clin Exp 15 (1995), 85-91.
2. J. Bishop and J.W. Simpkins, Estradiol enhances brain glucose uptake in ovariectomized rats, Brain Res Bull 36 (1995), 315-320.
3. H. Braak and E. Braak, Frequency of stages of Alzheimer-related lesions in different age categories, Neurobiol Aging 18 (1997), 351-357.
4. L. Buée, P.R. Hof, C. Bouras, A. Delacourte, D.P. Perl, C.H. Morrison and H.M. Fillit, Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders, Acta Neuropathol 87 (1994), 469-480.
5. M. Chen, N.C. Inestrosa, G.S. Ross and H.L. Fernandez, Platelets are the primary resource of amyloid-β in human blood, Biochem Biophys Res Commun 213 (1995), 96-103.
6. A.J. Dalton, A chrome-osmium tetroxide fixative for electron microscopy, Anat Rec 121 (1955), 121.
7. J. Davis Salinas, S.M. Saporito Irwin, C.W. Cotman and W.E. Van Nostrand, Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells, J Neurochem 65 (1995), 931-934.
8. J.C. de la Torre and T. Mussivand, Can disturbed brain circulation cause Alzheimer's disease? Neurol Res 15 (1993), 146-153.
9. D.B. Eisenhauer, R.T. Johnson, J.M. Wells, J.A. Davies and R.E. Fine, Toxicity of various amyloid-β peptide species in cultured human blood-brain barrier endothelial cells: Increased toxicity of Dutch-type mutant, J Neurosci 60 (2000), 804-810.
10. H.S. Forbes, Cerebral circulation, I. Observation and measurement of pial vessels, Arch Neurol Psychiat 15 (1928), 749-761.
11. G.G. Glemmer and C.W. Wong, Alzheimer's disease: initial report of purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Commmun 120 (1984), 885-890.
12. F. Gotoh, F. Muramatsu, H. Okayasu, I. Tanaka, N. Suzuki and M. Kobari, Video camera method for simultaneous measurement of blood flow velocity and vessel diameter, J Cerebr Blood Flow Metab 2 (1982), 421-428.
13. T. Iwatsubo, A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina and Y. Ihara, Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals evidence that an initially deposited species is Aβ42(43), Neuron 13 (1994), 45-53.
14. T. Iwatsubo, D.M. Mann, A. Odaka, N. Suzuki and Y. Ihara, Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Downs syndrome, Ann Neurol 37 (1995), 294-299.
15. J. Kang, H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, K.H. Grzeschik, G. Multhaup, K. Beyreuther and B. Müller-Hill, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature 325 (1987), 733-736.
16. M. Kawal, R.N. Kalaria, P. Cras, S.L. Siedlak, M.E. Velasco, E.R. Shelton, H.W. Chan, B.D. Greenberg and G. Perry, Degeneration of vascular smooth muscle cells in cerebral amyloid angiopathy of Alzheimer's disease, Brain Res 623 (1993), 142-146.
17. H.M. Koenig, D.A. Pelligrino and R.F. Albrecht, Halothane vasodilation and nitric oxide in rat pial vessels, J Neurosurg Anesthesiol 5 (1993), 264-271.
18. E.S. LeBlanc, J. Janowsky, B.K. Chan and H.D. Nelson, Hormone replacement therapy and cognition: systematic review and meta-analysis, JAMA 285 (2001), 1489-1499.
19. J.E. Levasseur, E.P. Wei, J. Raper, H.A. Kontos and J.L. Patterson, Jr., Detailed description of a cranial window technique for acute and chronic experiments, Stroke 6 (1975), 308-317.
20. J.B. Mackic, M.H. Weiss, W. Miao, E. Kirkman, J. Ghiso, M. Calero, J. Bading, B. Frangione and B.V. Zlokovic, Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid β peptide in aged squirrel monkey with cerebral amyloid angiopathy, J Neurochem 70 (1998), 210-215.
21. P.L. McGeer and E.G. McGeer, The inflammatory response system of brain: implementations for therapy of Alzheimer and other neurodegenerative diseases, Brain Res Rev 21 (1995), 195-218.
22. S. Morii, A.C. Ngai and H.R. Winn, Reactivity of rat pial arterioles and venules to adenosine and carbon dioxide: with detailed description of the closed cranial window technique in rats, J Cerebr Blood Flow Metab 6 (1986), 34-41.
23. J. Näslund, V. Haroutunian, M. Mohs, K.L. Davis, P. Greengard and J.D. Buxbaum, Correlation between elevated levels of amyloid-β-peptide in the brain and cognitive decline, J Am Med Assoc 283 (2000), 1571-1577.
24. R.M. Navari, E.P. Wei, H.A. Kontos and J.L. Patterson, Jr., Comparison of the open and closed cranial window preparations in the study of the cerebral microcirculation, Microvasc Res 16 (1978), 304-315.
25. T Ohkura, K. Isse, K. Akazawa, M. Hamamoto, Y. Yaoi and N. Hagino, Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type, Endocrine J 41 (1994), 361-371.
26. R. Prior, D. D'Urso, R. Frank, I. Prikulis, S. Cleven R. Ihl and G. Pavlakovic, Selective binding of soluble Aβ1-40 and Aβ1-42 to a subset of senile plaques, Am J Pathol 148 (1996), 1749-1765.
27. S.M. Resnick and V.W. Henderson, Hormone therapy and risk of Alzheimer disease. A critical time, JAMA 288 (2002), 2170-2172.
28. J. Rhodin, Correlation of ultrastructural organization and function in normal and experimentally changed proximal convoluted tubule cells of the mouse kidney, Thesis, Karolinska Institute, Stockholm, Sweden. 1954, pp. 1-76.
29. J. Rhodin, Fine structure of vascular walls in mammals with special reference to smooth muscle component, Physiol Reviews 42(5) (1962), 48-87.
30. J. Rhodin, The ultrastructure of mammalian arterioles and precapillary sphincters, J Ultrastruct Res 18 (1967), 181-223.
31. J. Rhodin, The ultrastructure of mammalian venous capillaries, venules and small collecting veins, J Ultrastruct Res 26 (1968), 452-500.
32. J. Rhodin, Fixation of microvasculature for electron microscopy, Microvasc Res 5 (1973), 285-291.
33. J. Rhodin, HISTOLOGY, A Text and Atlas, Monograph, Oxford University Press, New York, 1974, pp. 1-803.
34. J. Rhodin, Perfusion and superfusion fixation effects on rat mesentery microvascular beds. Intravital and electron microscope analyses, J Submicrosc Cytol Pathol 18 (1986), 453-470.
35. J. Rhodin and S. Lim Sue, Combined intravital microscopy and electron microscopy of the blind beginnings of the mesenteric lymphatic capillaries of the rat mesentery, Acta Physiol Scandinav 463(Suppl) (1979), 51-58.
36. J. Rhodin, T. Thomas, M.W. Bryant, L. Clark and E.T. Sutton, Animal model of vascular inflammation, J Submicrosc Cytol Pathol 31 (1999), 305-311.
37. J. Rhodin and T. Thomas, A vascular connection to Alzheimer's disease, Microcirculation 8 (2001), 207-220.
38. A.E. Rohrer, J.D. Lowenson, S. Clarke, A.S. Woods, R.J.Cotter, E. Gowing and M.J. Ball, β-Amyloid-(1-40) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease, Proc Natl Acad Sci USA 90 (1993), 10836-10840.
39. W.I. Rosenblum and B.W. Zweifach, Cerebral microcirculation in the mouse brain, Arch Neurol 9 (1963), 101-102.
40. R. Santizo and D.A. Pelligrino, Estrogen reduces leukocyte adhesion in cerebral circulation of female rats, J Cerebr Blood Flow Metab 19 (1999), 1061-1065.
41. E.T. Sutton, T. Thomas, M.W. Bryant, C.S. Landon, C.A. Newton and J.A.G. Rhodin, Amyloid-β peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1, J Submicrosc Cytol Pathol 31 (1999), 313-323.
42. T. Thomas, G. Thomas, C. McLendon, T. Sutton and M. Mullan, β-amyloid-mediated vasoactivity and vascular endothelial dysfunction, Nature 380 (1996), 168-171.
43. T. Thomas, E.T. Sutton, M.W. Bryant and J.A.G. Rhodin, In vivo vascular damage, leukocyte activation and inflammatory response induced by β-amyloid, J Submicrosc Cytol Pathol 29 (1997), 293-307.
44. T. Thomas, A role for estrogen in the primary prevention of Alzheimer's disease, Climacteric 4 (2001), 102-109.
45. T. Thomas, G.T. Nadackal and K. Thomas, Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-β aggregation, Neuroreport 12 (2001), 3263-3267.
46. E. Uhl, W. Stummer, J. Beck, L. Schürer and A. Baethmann, Leukocyte-endothelium interactions in the early reperfusion period after transient ischemia, J Cerebr Blood Flow & Metabolism 15(1) (1995), S134.
47. B. Urmoneit, I. Prikulis, W. Günther, D. D'Urso, F. Rainer, J. Heeren, U. Beisiegel and R. Prior, Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy, Lab Investig 77 (1997), 157-166.
48. C. Vigo-Pelfrey, D. Lee, P. Keim, I. Lieberburg and D.B. Schenk, Characterization of β-amyloid peptide from human cerebrospinal fluid, J Neurochem 61 (1993), 1965-1968.
49. A. Villringer, U. Dimagl, A. Them, L. Schürer, F. Krombach and L. Einhäupl, Imaging of leukocytes within the rat brain cortex in vivo, Microvasc Res 42 (1991), 305-315.
50. Writing Group for Women's Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy menopausal women: principal results from Women's Health Initiative randomized controlled trial, J Am Med Assoc 288 (2002), 321-333.
51. K. Yaffe, Hormone therapy and the brain. Deja Vu all over again? JAMA 289 (2003), 2717-2719.
52. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Rohrer, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stem and A.M. Schmidt, RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease, Biochem Biophys Res Comm 382 (1996), 685-691.
53. P.P. Zandi, M.C. Carlson, B.L. Plassman, K.A. Welsh-Bohmer, L.S. Mayer, D.C. Steffens and J.C.S. Breitner, Hormone replacement therapy and incidence of Alzheimer disease in older women. The Cache County study, J Am Med Assoc 288 (2002), 2123-2129.
54. B.V. Zlokovic, Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology? Neurobiol Dis 4 (1997), 23-26.
55. B.V. Zlokovic, J. Ghiso, J.B. Mackic, J.G. McComb, M.H. Weiss and B. Frangione, Blood-brain barrier transport of circulating Alzheimer's amyloid β, Nature 197 (1993), 1034-1040.